Page last updated: 2024-10-30

mebendazole and Infant Malnutrition

mebendazole has been researched along with Infant Malnutrition in 1 studies

Mebendazole: A benzimidazole that acts by interfering with CARBOHYDRATE METABOLISM and inhibiting polymerization of MICROTUBULES.
mebendazole : A carbamate ester that is methyl 1H-benzimidazol-2-ylcarbamate substituted by a benzoyl group at position 5.

Infant Malnutrition: Malnutrition, occurring in infants ages 1 month to 24 months, which is due to insufficient intake of food, dietary nutrients, or a pathophysiologic condition which prevents the absorption and utilization of food. Growth and development are markedly affected.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Diouf, S1
Diagne, I1
Moreira, C1
Signate, SY1
Faye, O1
Ndiaye, O1
Sylla, A1
Diallo, I1
Thiam, D1
Diop, B1
Thiam, I1
Gaye, I1
Sarr, M1
Fall, M1

Other Studies

1 other study available for mebendazole and Infant Malnutrition

ArticleYear
[Integrated treatment of iron deficiency, vitamin A deficiency and intestinal parasitic diseases: impact on Senegalese children's growth].
    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2002, Volume: 9, Issue:1

    Topics: Anemia, Iron-Deficiency; Anti-Infective Agents; Antinematodal Agents; Child Nutrition Disorders; Chi

2002